Sean T. Smith
Analyst · Bank of America
Thanks, Deno, and good morning, everyone. I'll provide a brief analysis of our financial results for the third quarter of 2013, also review our balance sheet and cash flows and then provide our outlook for Q4. As Deno mentioned, we successfully completed the tender offer for PSMC and now own 98.1%. In addition to the strategic importance of this transaction, we expect it to be accretive going forward. The minority interest expense for Q3 was approximately $400K since the transaction was concluded in mid-quarter. Had we not acquired the additional 23% of PSMC, minority interest expense would have been in excess of $700,000. Please turn to -- read Slides 5, 6 and 7, which show our sequential and year-to-date IC and FPD performance. Third quarter revenues totaled $109.7 million, within our guided range of $107 million to $111 million. Revenues for IC and FPD photomasks were $84.2 million and $25.5 million, respectively, for the third quarter. Breaking out sales geographically, 59% of total sales were from Asia; 31% from North America; and 10% from Europe. As Deno discussed, high-end global IC sales were somewhat muted during the quarter with sales of $22.9 million, down $400,000 compared to the second quarter. We did experience some delayed tape-outs for memory products due to the improved memory pricing during the quarter, as our memory customers generally continue to manufacture existing devices. We also experienced continued softness with one of our foundry customers due in part to a node migration for which we had not yet completed qualification. We are optimistic in completing this qualification during the current quarter. Advanced FPD sales were $16.7 million, a sequential increase of $200,000. Advanced FPD sales represented 65% of total FPD sales for the quarter. As a reminder, high-end IC revenue consists -- high-end IC revenues derived from semi-designs at and below 45 nanometers and high-end FPD revenues consist of revenue at and above G8, as well as AMOLED-based products. Now let's continue through the income statement. Gross margin for the third quarter was 24.7%, up sequentially by 150 basis points as a result of the increased sales and reduced manufacturing costs. The incremental margin contribution was approximately 77% on the increased sales, primarily driven by reduced labor and benefits. Selling and general administrative expenses for the third quarter were $12.1 million, essentially flat with the second quarter. R&D expenses, which consist principally of continued development of our global advanced process technologies and qualifications at advanced nodes, were $5 million, up approximately $400,000 sequentially as a result of increased qualifications. During the quarter, we generated operating income of $10 million or 9.1% of sales, a sequential improvement of 150 basis points. The incremental margin contribution was approximately 65% on the increased sales, primarily as a result of reduced manufacturing costs. Noncash stock comp was approximately $1 million during the quarter. Please turn to Slide 8. EBITDA, as defined in our credit agreement, was $29.2 million or $112 million on a trailing 12-month basis. Other income and expense for the third quarter was expense of $1 million, up $100k sequentially. And during the quarter, we recorded a tax provision of $2.7 million, which was within our guided range of $2 million to $3 million. GAAP net income was $5.9 million or $0.10 per diluted share. And at the end of the third quarter, we had approximately 1,300 full-time employees. This equates to revenue per employee of $337,000 on an annualized basis. Now turning to the balance sheet. Cash and cash equivalents at quarter end amounted to $197 million, and our net cash, which is cash less debt, was $3 million, down $28 million sequentially. This was principally as a result of the completion of our tender offer for PSMC shares, for which we utilized approximately $27.4 million of cash during the quarter. We have taken PSMC private, and as I stated earlier, we own over 98%. Our working capital at the end of the quarter was $192 million, down from $207 million or $15 million as compared to Q2, primarily as a result of the cash we used for the PSMC transaction. Accounts payable and accrued current liabilities at quarter end amounted to $110 million. And at the end of Q3 2013, $30 million of CapEx was accrued for. Please turn to Slide 9, as we review our capitalization. Total debt at quarter end was $194 million. The principal components of outstanding debt include: $22 million of the 5.5% senior unsecured notes due October of 2014; $115 million, 3.25% senior convertible note due April 2016; $12 million related to a capital lease obligation; $22 million 2.5% 5-year term loan related to the nanoFab building; and approximately $23 million related to a 2.5% capital lease for the advanced e-beam tool. At the end of Q3, we did not have any outstanding borrowings on our $30 million revolving credit line that matures in April 2015. Additionally, in connection with the PSMC transaction, our equity decreased approximately $27 million during the quarter as a result of the elimination of PSMC minority interest. Taking a look at our cash flows. Cash provided by operations for the third quarter of 2013 was approximately $32 million and was $68 million year-to-date. Depreciation and amortization was $17.6 million for the quarter. Cash flow used in investing activities during Q3 amounted to $15 million and $50 million year-to-date. Year-to-date cash used in investing activities includes $47 million of cash CapEx. Net cash used in financing activities during Q3 amounted to $29 million and $36 million year-to-date. As I previously mentioned, during the quarter, we invested $27 million through the tender offer for PSMC. Please turn to Slide 10 as we take a look ahead. We expect our non-financed cash CapEx in 2013 to be in the range of $65 million to $75 million. We expect to continue to generate free cash flow, once again, in 2013. And our 2013 investments have been principally geared towards high-end, leading-edge products for both IC and FPD applications. Our visibility, as always, continues to be limited as our backlog is typically 1 to 2 weeks. For Q4, we do expect to experience some typical seasonality related to the U.S. and European summer and holiday vacation seasons. As a result, we are projecting the revenue for the fourth quarter of 2013 to be in the range of $110 million to $114 million. During 2013, our tax rate will be affected by the flow of income from jurisdictions for which we may have tax credits and upon our limited ability to recognize tax benefits in areas which we are taxable. For the fourth quarter of 2013, we expect this to -- we expect this will equate to a range of $2 million to $3 million. For fiscal 2013, we estimate total taxes to be in the range of $8 million to $9 million. As a result, based upon our current operating model, we estimate earnings per share for the fourth quarter to be in the range of $0.10 to $0.13. Please turn to Slide 11. I'll leave you with a few key thoughts. We do expect further top and bottom line sequential improvement in Q4. And looking into the latter part of Q4 and into fiscal 2014, we expect accelerated high-end IC growth as we capitalize on continued opportunities in our customers' businesses and node migration plans. We believe that we are well positioned to become the leading global merchant photomask supplier as a result of our advanced technology, strategically deployed leading-edge capacity and strong financial position. We expect to benefit from our increased high-end capacity strategically located in Boise and in Asia. The capacity is in line with our foundry customers' node migration plans, as well as our Boise JV partner's growth prospects in Asia. Now I'd like to turn the call over to the operator for Q&A.